tiprankstipranks
Annexon Biosciences (ANNX)
NASDAQ:ANNX
US Market

Annexon Biosciences Income Statement

92 Followers

Annexon Biosciences Income Statement

Last quarter (Q2 2022), Annexon Biosciences's total revenue was $0.00, a decrease of ― from the same quarter last year. In Q2, Annexon Biosciences's net income was $-37.14M. See Annexon Biosciences’s key income statements, including revenue, expenses, profit, and income.
Income Statement
TTM
Dec 21Dec 20Dec 19Dec 18
Total Revenue
-$ 0.00$ 0.00$ 0.00$ 0.00
Cost of Revenue
-----
Gross Profit
-----
Operating Expense
$ 145.97M$ 130.71M$ 63.47M$ 32.52M$ 19.15M
Operating Income
$ -145.97M$ -130.71M$ -63.47M$ -32.52M$ -19.15M
Net Non Operating Interest Income Expense
$ 412.00K$ 390.00K$ 57.00K--
Other Income Expense
$ 82.00K-$ 57.00K$ -4.66M$ 844.00K
Pretax Income
$ -145.48M$ -130.32M$ -63.41M$ -37.18M$ -18.30M
Tax Provision
-$ 0.00$ 0.00$ 4.00K$ 1.00K
Earnings From Equity Interest Net Of Tax
-----
Net Income Common Stockholders
$ -145.48M$ -130.32M$ -70.34M$ -38.28M$ -18.48M
Basic EPS
$ -3.78$ -3.40$ -4.15$ -2.75$ -1.61
Diluted EPS
$ -3.78$ -3.40$ -4.15$ -2.75$ -1.61
Basic Average Shares
$ 153.97M$ 38.32M$ 16.96M$ 11.45M$ 11.45M
Diluted Average Shares
$ 153.97M$ 38.32M$ 16.96M$ 11.45M$ 11.45M
Dividend Per Share
-----
Total Operating Income As Reported
-----
Reported Normalized Basic E P S
-----
Reported Normalized Diluted E P S
-----
Rent Expense Supplemental
-----
Total Expenses
$ 145.97M$ 130.71M$ 63.47M$ 32.52M$ 19.15M
Net Income From Continuing And Discontinued Operation
$ -145.48M$ -130.32M$ -63.41M$ -37.18M$ -18.30M
Normalized Income
$ -145.48M$ -130.32M$ -63.41M$ -37.18M$ -18.30M
Interest Expense
-----
EBIT
$ -145.97M$ -130.71M$ -63.47M$ -32.52M$ -19.15M
EBITDA
$ -143.85M$ -128.57M$ -62.80M$ -32.02M$ -18.66M
Currency in USD

Annexon Biosciences Earnings and Revenue History


What's Included in PREMIUM?
Make informed decisions based on Top Analysts' activity
Know what industry insiders are buying
Get actionable alerts from top Wall Street Analysts
Find out before anyone else which stock is going to shoot up
Get powerful stock screeners & detailed portfolio analysis